Research

Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346383/

Learn more
Early Bortezomib Therapy for Refractory Anti-NMDA Receptor Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118211/

Learn more
Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051207/

Learn more
Immune Activation and Deficit in Neurotransmitters Synthesis in Treatment Resistant Depression: About a Case of Hashimoto Encephalopathy February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383012/

Learn more
Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217659/

Learn more
The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536844/

Learn more
Effect of Clozapine on Anti-N-Methyl-D-Aspartate Receptor Encephalitis With Psychiatric Symptoms: A Series of Three Cases February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465601/

Learn more
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705619/

Learn more
Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783555/

Learn more
GABAA receptor autoimmunity February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501640/

Learn more